Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review

Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review

<p>Abstract</p> <p>Background</p> <p>Compared to conventional human basal insulin (neutral protamine Hagedorn; NPH) the long-acting analogue insulin glargine (GLA) is associated with a number of advantages regarding metabolic control, hypoglycaemic events and convenienc...

Full description

Bibliographic Details
Main Authors: Dippel Franz-Werner, Koltermann Katharina C, Hagenmeyer Ernst-Günther, Schädlich Peter K
Format: Article
Language:English
Published: BMC 2011-10-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Systematic review
health economics
type 1 diabetes
basal-bolus therapy
insulin glargine
NPH
Online Access:http://www.resource-allocation.com/content/9/1/15

Similar Items

Similar Items